The next generation sequencing market growth continues to demonstrate resilience as rare disease diagnostics achieves breakthrough capabilities that were previously unimaginable with traditional testing approaches. NGS technologies, particularly whole-exome and whole-genome sequencing, have revolutionized the diagnostic odyssey for patients with suspected genetic disorders, achieving diagnostic...